← Open Payments lookup

JON GAMBILL: Open Payments

NPI 1073586319 · CANYONVILLE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$407 in 20 payments from 10 companies in 2025. Trend: 2023 $436 · 2024 $536 · 2025 $407

Food & beverage: $407
CompanyPaymentsAmount
Amgen Inc.8$162
ABBVIE INC.3$71
GlaxoSmithKline, LLC.1$30
AstraZeneca Pharmaceuticals LP2$28
Boehringer Ingelheim Pharmaceuticals, Inc.1$22
Edwards Lifesciences Corporation1$22
Novo Nordisk Inc1$21
Xeris Pharmaceuticals, Inc.1$20
Lundbeck LLC1$16
Sumitomo Pharma America, Inc.1$15

Products named: EVENITY, REPATHA, VRAYLAR, OTEZLA, TRELEGY ELLIPTA, MAVYRET, JARDIANCE, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve.

Industry payments across OR — which companies pay providers there.